Molecular BiologybioRxivPreprint
SF3b inhibitors suppress proliferation of nonsmall cell lung cancer cells irrespective of EGFR mutation status
Wataru Fukagawa, Yuta Horita, Hiroyoshi Harada…·Kenji Ohe
The paper tests SF3b inhibitors on NSCLC cells with different EGFR statuses, finding growth suppression regardless of EGFR mutation, suggesting a mechanism independent of EGFR kinase activity.
DOI 10.64898/2026.10.29.762206